The average one-year price target for Minerva Neurosciences, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price target. Track Minerva Neurosciences Inc (NERV) Stock Price, Quote, latest community messages, chart, news and other stock related information. Minerva Neurosciences Forecast Revenue Growth Analysts estimate an earnings increase this quarter of $ per share, an increase next quarter of $ per. Wall Street analysts forecast NERV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NERV. On average, analysts forecast that NERV's EPS will be -$ for , with the lowest EPS forecast at -$, and the highest EPS forecast at -$ On.
Minerva Neurosciences has a consensus price target of $ Q. Current stock price for Minerva Neurosciences (NERV)?. A. The stock price for. Minerva Neurosciences (NERV) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. View Minerva Neurosciences Inc NERV stock quote prices, financial information, real-time forecasts, and company news from CNN. NERV EPS for the last quarter is − USD despite the estimation of − USD. In the next quarter EPS is expected to reach − USD. Track more of Minerva. View Minerva Neurosciences (NERV) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Get Minerva Neurosciences Inc (NERV:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Given the current short-term trend, the stock is expected to fall % during the next 3 months and, with a 90% probability hold a price between $ and. Minerva Neurosciences NERV share price targets for July month are on upside & on downside · Minerva Neurosciences, Inc NERV share price target for year. Minerva Neurosciences (NERV) adaptive stock price forecast & ideologically balanced news. Transparently evaluate AI model performance. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. NERV will report earnings. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to.
The current price of NERV is USD — it has increased by % in the past 24 hours. Watch Minerva Neurosciences, Inc stock price performance more closely on. Find the latest Minerva Neurosciences, Inc. (NERV) stock quote, history, news and other vital information to help you with your stock trading and investing. Future price of the stock is predicted at $ (%) after a year according to our prediction system. This means that if you invested. Minerva Neurosciences (NASDAQ:NERV) Stock, Earnings Estimates, EPS, And Revenue ; NERV. Minerva Neurosciences. -$ ; NERV. Minerva Neurosciences. -$ ; NERV. Hold Rating on Minerva Neurosciences Amid Regulatory Uncertainty and Financial Constraints. Aug. 7, at a.m. ET ; Minerva price target lowered to $5. The share price as of August 23, is / share. Previously, on August 28, , the share price was / share. This represents a decline of %. Earnings and Valuation · Earnings Growth. Earnings for Minerva Neurosciences are expected to decrease in the coming year, from ($) to ($) per share. The 1 analyst with a month price forecast for NERV stock has a target of , which predicts an increase of % from the current stock price of Only one analyst offered a short-term price target of $ for Minerva Neurosciences. This represents an increase of % from the last closing price of.
NERV Price · $ ; Market Cap · $M ; 52 Week Low · $ ; 52 Week High · $ ; P/E · x. The Minerva Neurosciences stock forecast for tomorrow is $ , which would represent a % loss compared to the current price. In the next week, the price. View Minerva Neurosciences Inc (NERV) stock price today, market news, streaming charts, forecasts and financial information from FX Empire. Tomorrow's movement Prediction of Minerva Neurosciences, Inc NERV appears strongly Bullish. This stock started moving upwards as soon as it opened. Generally. Investors in Minerva Neurosciences, Inc. NERV need to pay close attention to the stock based on moves in the options market lately. That is because the Jul
Price to Book Ratio vs Industry ; NERV Minerva Neurosciences. n/a, %, US$m ; ABBV AbbVie. x, %, US$b. Analyst. Target Price · 1 analysts ; Earnings. EPS Estimate. Due Feb 22 ; Investor. New Investor. Northern Trust.